Advance Notice of Proposed Rulemaking: International Price Index Model for Medicare Part B Drugs


The National Health Council (NHC) appreciates the opportunity to respond to the Centers for Medicare & Medicaid Services’ (CMS’) Advance Notice of Proposed Rulemaking entitled, “International Price Index Model for Medicare Part B Drugs” (the IPI Model). The NHC continues to support CMS in testing new models of care that align payment incentives with value and quality; engage patients in defining high-value, high-quality care; focus on outcomes that matter to patients; and facilitate efficient arrangements among stakeholders.

Read More